hc1 Named to TIME’s World’s Top HealthTech Companies of 2026. Report →

By Jason Carney, SVP Clinical Strategy
Share

Clinical Strategy

Women’s health is finally getting the investment and attention it deserves, and HLTH 2026 is where that momentum comes together with AI and the business of care. I’m excited to be in Las Vegas, November 15–18, to connect with the leaders turning that attention into better outcomes.

What I’m Looking Forward to at HLTH 2026

  1. Closing care gaps that start in the lab. I’m looking forward to connecting with leaders focused on addressing gaps in women’s health that too often go undetected. Earlier identification of conditions like anemia can make a meaningful difference in patient outcomes. I’m excited to explore how we can continue advancing Clinical IQ™ to make early detection and intervention a routine part of care.
  2. Where clinical quality and financial performance meet. When a lab result leads to the right action at the right time, we can reduce unnecessary testing, avoid downstream costs, and improve patient outcomes. Those are the conversations I want to be part of, especially as we look to expand Clinical IQ™ into the payer market, connecting health plans and providers to identify care gaps, improve quality, and drive better outcomes across patient populations.
  3. Seeing AI move from the keynote to the bedside. I’m most looking forward to seeing how healthcare organizations are moving beyond the conversation around AI and putting it into clinical practice. That’s exactly what we’re building with Clinical IQ, turning lab data into actionable intelligence that helps clinicians make better decisions and improve patient care.

Lab data is the earliest signal in healthcare, and it’s time health plans put it to work.

About Clinical IQ™

hc1 Clinical IQ™ turns lab results and clinical data into action, using clinician-built AI to help care teams close gaps across anemia management, patient blood management, women’s health, and lab stewardship. It works inside the EHR, so insights appear where teams already work.

Going to HLTH 2026?

Book time with me to talk women’s health, lab data, and what Clinical IQ can do for payers and providers.

Book Time With Me

Or learn more about hc1 Clinical IQ™.

By John Markloff, VP of Data Strategy
Share

Data Strategy

As healthcare’s leading innovation event, HLTH 2026 brings together industry leaders shaping the future of care. I’m excited to be in Las Vegas, November 15–18, to connect with peers and explore the latest innovations in healthcare.

What I’m Looking Forward to at HLTH 2026

  1. Building meaningful connections. I’m eager to connect and collaborate with peers who share a commitment to using lab data as proactive intelligence to improve patient outcomes.
  2. Integrating AI into clinical decision-making. Looking forward to seeing how forward-thinking healthcare leaders are leveraging clinical data to detect risks earlier, address gaps in care, and guide actionable next steps for providers.
  3. Accelerating time to diagnosis and care. I’m excited to explore how lab data can help life sciences and diagnostics companies better understand testing trends and deliver timely, actionable insights to clinicians, ultimately helping patients get the care they need sooner.

About Signal IQ

Signal IQ™ provides de-identified, tokenized real-world lab data to help life sciences and healthcare organizations uncover insights from testing patterns and patient journeys.

Our dataset includes 95M+ unique patient profiles and 12B+ historical lab results spanning more than a decade, with 100M+ new lab results added each month.

Going to HLTH 2026?

Book time with me to talk lab data, AI, and earlier clinical signals.

Book Time With Me

Or learn more about hc1 Signal IQ.